Inventor · disambiguated record
Shannon Marshall
Also filed as: MARSHALL SHANNON · MARSHALL SHANNON A · MARSHALL SHANNON ALICIA
13 granted patents·22 pending applications·351 citations·filing 1997–2024
92Inventor score
Top patents by PatentIndex Score
35 records- 0197US9205148B2Antibodies and other molecules that bind B7-H1 and PD-1LANGERMANN SOLOMON·Filed 2012·Granted Dec 8, 2015·243 cites·22 claims
- 0293US8338569B2FGFR extracellular domain acidic region muteinsMARSHALL SHANNON·Filed 2009·Granted Dec 25, 2012·42 cites·5 claims
- 0386US9676854B2Anti-B7-H4 antibodies and their usesLIU LINDA·Filed 2012·Granted Jun 13, 2017·17 cites·24 claims
- 0484US9011853B2B7-H4 fusion proteins and methods of use thereofLANGERMANN SOLOMON·Filed 2010·Granted Apr 21, 2015·8 cites·43 claims
- 0584US7459527B2BMP-7 variants with improved propertiesXENCOR INC·Filed 2005·Granted Dec 2, 2008·6 cites·2 claims
- 0683US9957312B2B7-H4 fusion proteins and methods of use thereofMEDIMMUNE LLC·Filed 2015·Granted May 1, 2018·4 cites·54 claims
- 0780US8324165B2Compositions for treating arthritis comprising HG1023575 polypeptidePENTA KALYANI·Filed 2009·Granted Dec 4, 2012·4 cites·3 claims
- 0878US7381792B2Variants of RANKL proteinXENCOR INC·Filed 2003·Granted Jun 3, 2008·9 cites·14 claims
- 0972US8575312B2Compositions and methods of use for MGD-CSF in disease treatmentBEHRENS DIRK·Filed 2012·Granted Nov 5, 2013·2 cites·11 claims
- 1069US7399829B2Variants of RANKL proteinXENCOR INC·Filed 2003·Granted Jul 15, 2008·5 cites·12 claims
- 1166US2024301027A1Treatment of mage-a4 positive cancerIMMUNOCORE LTD·Filed 2024·Application pending·0 cites
- 1263US8178109B2Compositions and methods of use for MGD-CSF in disease treatmentBEHRENS DIRK·Filed 2009·Granted May 15, 2012·0 cites·12 claims
- 1362US2004230380A1Novel proteins with altered immunogenicityXENCOR INC·Filed 2004·Application pending·0 cites
- 1460US2025333504A1TreatmentIMMUNOCORE LTD·Filed 2022·Application pending·0 cites
- 1558US2006235204A1BMP-2 variants with improved propertiesXENCOR INC·Filed 2006·Application pending·0 cites
- 1657US2014170145A1Compositions and methods of use for mgd-csf in disease treatmentFIVE PRIME THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 1756US2008070837A1BMP-4 variants with improved propertiesXENCOR INC·Filed 2006·Application pending·0 cites
- 1854US2005079155A1Generating protein pro-drugs using reversible PPG linkagesXENCOR INC·Filed 2004·Application pending·0 cites
- 1953US9175065B2FGFR extracellular domain acidic region muteinsMARSHALL SHANNON·Filed 2012·Granted Nov 3, 2015·0 cites·9 claims
- 2053US2004137581A1Interferon variants with improved propertiesXENCOR INC·Filed 2003·Application pending·0 cites
- 2153US2005054053A1Interferon variants with improved propertiesXENCOR INC·Filed 2004·Application pending·0 cites
- 2252US2004110226A1Antibody optimizationXENCOR INC·Filed 2003·Application pending·0 cites
- 2352US2005064555A1Ciliary neurotrophic factor variantsXENCOR INC·Filed 2004·Application pending·0 cites
- 2451US2006073563A1Erythropoietin derivatives with altered immunogenicityXENCOR INC·Filed 2005·Application pending·0 cites
- 2551US2004121953A1Thrombopoiesis-stimulating proteins having reduced immunogenicityFiled 2003·Application pending·0 cites
- 2651US2007264277A1Compositions and Methods of Use for Mgd-Csf in Disease TreatmentBEHRENS DIRK·Filed 2005·Application pending·0 cites
- 2746US2004175359A1Novel proteins with antiviral, antineoplastic, and/or immunomodulatory activityFiled 2003·Application pending·0 cites
- 2844US2006275282A1Antibodies and Fc fusion proteins with altered immunogenicityXENCOR INC·Filed 2006·Application pending·0 cites
- 2943US6054711AMethods for identifying biological macromolecule interactions with compounds, particularly in complex mixturesMILLENNIUM PHARM INC·Filed 1997·Granted Apr 25, 2000·11 cites·20 claims
- 3043US2016130348A1Antibodies and other molecules that bind b7-h1 and pd-1MEDIMMUNE LLC·Filed 2015·Application pending·0 cites
- 3143US2006030525A1Apolipoprotein A-I derivatives with altered immunogenicityXENCOR INC·Filed 2005·Application pending·0 cites
- 3243US2006014248A1TNF super family members with altered immunogenicityXENCOR INC·Filed 2005·Application pending·0 cites
- 3342US2011319324A1Methods of and compositions for stimulation of glucose uptake into muscle cells and treatment of diseasesLIN JUNYU·Filed 2010·Application pending·0 cites
- 3442US2007054851A1Methods of and compositions for stimulation of glucose uptake into muscle cells and treatment of diseasesLIN JUNYU·Filed 2006·Application pending·0 cites
- 3542US2005266464A1C1q family member proteins with altered immunogenicityXENCOR INC·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Shannon Marshall files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →